INVESTORS & MEDIA
Corporate Governance
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Sep 18, 2013 |
Director, Chairman of the Board
Trans History: 692
|
Director, Chairman of the Board | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 312,500 | -- |
| Nov 23, 2012 |
Director, Chairman of the Board
Trans History: 692
|
Director, Chairman of the Board | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 312,500 | $19.43 |
| Nov 23, 2012 |
Director, Chairman of the Board
Trans History: 692
|
Director, Chairman of the Board | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 312,500 | -- |
| Aug 31, 2011 |
Director, Chairman of the Board
Trans History: 692
|
Director, Chairman of the Board | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 312,500 | $28.01 |
| Aug 31, 2011 |
Director, Chairman of the Board
Trans History: 692
|
Director, Chairman of the Board | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 312,500 | -- |
| Dec 15, 2003 |
Director
Trans History: 692
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 312,500 | -- |
| Nov 18, 2019 |
Director, President and CSO
Trans History: 581
|
Director, President and CSO | Bona fide gift | 325,986 | -- |
| Nov 18, 2019 |
Director, President and CSO
Trans History: 581
|
Director, President and CSO | Bona fide gift | 325,986 | -- |
| Jan 05, 2005 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 581
|
Director, EVP, CSO, & Pres Regn Res Labs | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | 333,000 | -- |
| Jun 27, 2005 |
Director
Trans History: 692
|
Director | Bona fide gift | 348,923 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.